# Samsara Biocapital, LLC

> Samsara Biocapital, LLC is an SEC-registered investment advisory firm, registered since 2018, reporting $1 billion to $5 billion in regulatory assets under management in its Form ADV filing dated June 26, 2026.

- CRD: 288114
- Filed as: SAMSARA BIOCAPITAL, LLC
- Registration: SEC-registered investment adviser (status as filed: Approved)
- Filing period: October 2026
- Form ADV filing dated: June 26, 2026
- SEC record (IAPD): https://adviserinfo.sec.gov/firm/summary/288114
- AdvisorCensus page: https://advisorcensus.com/firm/samsara-biocapital-llc-288114

## Quick answers

**How is Samsara Biocapital, LLC compensated?**
On its Form ADV (Item 5.E, October 2026), Samsara Biocapital, LLC reports these compensation arrangements: a percentage of assets under its management; performance-based fees. The amounts are in Item 5 of its Form ADV Part 2A brochure.

**Is Samsara Biocapital, LLC registered with the SEC or a state?**
Samsara Biocapital, LLC is an SEC-registered investment advisory firm, registered since 2018. Status as filed: Approved. CRD 288114.

**How much does Samsara Biocapital, LLC manage?**
Samsara Biocapital, LLC reports $2,170,095,404 in regulatory assets under management in its Form ADV filing dated June 26, 2026 (100% discretionary).

**How have Samsara Biocapital, LLC's assets and staff changed since 2021?**
In the Form ADV data for Samsara Biocapital, LLC: Regulatory assets under management: $972,486,261 in the October 2021 data and $2,170,095,404 in the October 2026 data, up 123%. Total employees: 19 in October 2021 and 31 in October 2026. Assets under management move with markets as well as with clients coming and going.

**What types of clients does Samsara Biocapital, LLC serve?**
By number of clients on Form ADV Item 5.D: pooled investment vehicles (other than investment companies and business development companies) (3).

**Does Samsara Biocapital, LLC report any disciplinary disclosures?**
Reports no disclosure items on Form ADV Item 11. The detail of any item is on the firm's SEC record: https://adviserinfo.sec.gov/firm/summary/288114

**What changed in Samsara Biocapital, LLC's recent Form ADV filings?**
In the July 2026 filing data: Updated its list of owners and control persons (Schedule A).

## From the Form ADV filing

### Compensation (Item 5.E)
- A percentage of assets under your management
- Performance-based fees

### Regulatory assets under management (Item 5.F)
- Total: $2,170,095,404
- Discretionary: $2,170,095,404
- Non-discretionary: $0

### Clients (Item 5.D)

| Client type | Clients | Assets |
| --- | --- | --- |
| Pooled investment vehicles (other than investment companies and business development companies) | 3 | $2,170,095,404 |

### Advisory services (Item 5.G)
- Portfolio management for pooled investment vehicles (other than investment companies)

### Firm details
- Registered since: 2018 (8 years)
- Employees: 31 total, 22 performing advisory functions
- Wrap fee program participation: No
- States registered or notice-filed: CA
- Disclosures (Item 11): Reports no disclosure items on Form ADV Item 11.

### Websites listed on Form ADV (Item 1.I)
- samsaracap.com
- X @SAMSARABIOCAP
- X @SAMSARACAP

## Assets and staff over time

| Data period | Regulatory assets under management | Employees | Filing dated |
| --- | --- | --- | --- |
| October 2021 | $972,486,261 | 19 | March 31, 2021 |
| October 2022 | $1,144,019,216 | 22 | April 1, 2022 |
| October 2023 | $1,365,987,964 | 30 | April 26, 2023 |
| October 2024 | $1,622,845,390 | 26 | March 31, 2024 |
| October 2025 | $1,859,634,308 | 25 | March 31, 2025 |
| October 2026 | $2,170,095,404 | 31 | June 26, 2026 |

Regulatory assets under management: $972,486,261 in the October 2021 data and $2,170,095,404 in the October 2026 data, up 123%.
Total employees: 19 in October 2021 and 31 in October 2026.

## Changes in the filing (last 12 months)

### July 2026
- Updated its list of owners and control persons (Schedule A).

### April 2026
- Employees performing advisory functions went from 16 to 22.
- Regulatory assets under management went from $1,859,634,308 to $2,170,095,404 (+17%).

## Source

Form ADV as filed, October 2026. Values appear as filed. Cite as: AdvisorCensus. Samsara Biocapital, LLC (CRD 288114): Form ADV filing data as of October 2026.